Phase III Rinvoq Win in Crohn’s; Meat After CRC Dx? Kidney Disease and Cirrhosis
Another phase III study of upadacitinib (Rinvoq) induction in moderate to severe Crohn's disease showed significantly improved rates of clinical…
Browsing Tag
Rinvoq
Rinvoq Shows Promise in Spine Disease
The oral selective JAK-1 inhibitor upadacitinib (Rinvoq) showed efficacy through 1 year among patients with ankylosing spondylitis in a phase…